Pharming (PHAR) Cash from Financing Activities (2019 - 2023)
Historic Cash from Financing Activities for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$5.3 million.
- Pharming's Cash from Financing Activities fell 106607.54% to -$5.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$5.3 million, marking a year-over-year increase of 3849.12%. This contributed to the annual value of -$2.4 million for FY2021, which is 10392.18% down from last year.
- Latest data reveals that Pharming reported Cash from Financing Activities of -$5.3 million as of Q2 2023, which was down 106607.54% from -$2.9 million recorded in Q4 2022.
- In the past 5 years, Pharming's Cash from Financing Activities ranged from a high of $3.3 million in Q3 2022 and a low of -$62.7 million during Q4 2019
- For the 5-year period, Pharming's Cash from Financing Activities averaged around -$8.6 million, with its median value being -$2.6 million (2021).
- Within the past 5 years, the most significant YoY rise in Pharming's Cash from Financing Activities was 21748.06% (2022), while the steepest drop was 12128655.46% (2022).
- Quarter analysis of 5 years shows Pharming's Cash from Financing Activities stood at -$62.7 million in 2019, then skyrocketed by 100.1% to $63326.1 in 2020, then crashed by 3858.32% to -$2.4 million in 2021, then dropped by 21.39% to -$2.9 million in 2022, then crashed by 82.04% to -$5.3 million in 2023.
- Its Cash from Financing Activities was -$5.3 million in Q2 2023, compared to -$2.9 million in Q4 2022 and $3.3 million in Q3 2022.